期刊文献+

亚细胞毒性剂量As_2O_3增加胃癌细胞对rhTRAIL的敏感性及其机制 被引量:3

Subcytotoxic concentration of arsenic trioxide enhances the sensitivity of SGC7901 cells to rhTRAIL and its mechanism
下载PDF
导出
摘要 目的:研究亚细胞毒性剂量As2O3对rhTRAIL诱导胃癌细胞凋亡的影响及其机制.方法:人胃腺癌细胞株SGC 7901以As2O3(1μmol/L),rhTRAIL(500μg/L)及两者联用处理:采用AnnexinV-FITC和PI双染色流式细胞仪检测细胞凋亡:用间接免疫荧光染色结合流式细胞技术检测细胞表面TRAIL R1/DR4和TRAIL R2/DR5分子表达;RT-PCR方法检测TRAIL R1/DR4和TRAIL R2/DR5 mRNA表达.结果:rhTRAIL在单用或与As2O3联用时均可以诱导胃癌SGC7901细胞凋亡,并且随着作用时间延长(12-72 h),细胞凋亡率逐渐增高.As2O3与rhTRAIL联用24,48,72 h后,SGC7901细胞凋亡率分别显著高于单用rhTRAIL处理相同时间细胞(36.49%±7.12%,47.13%±3.44%,55.63%±7.16%vs 29.78%±3.18%、38.56%±1.89%,43.12%±6.23%,P<0.05); As2O3单用或联用rhTRAIL处理SGC7901细胞24 h后,细胞表面TRAIL R1/DR4和TRAIL R2/DR5分子的平均荧光密度(MFI)较对照组细胞显著增加(R1/DR4:29.44±4.29,26.14±3.40 vs13.45±3.81,P<0.05或P<0.01;R2/DR5:28.04±0.79.3 1.47±4.56vs16.45±5.07,P<0.05或P<0.01);与此同时,TRAIL R1/DR4和TRAIL R2/DR5mRNA表达水平增高.结论:亚细胞毒性剂量As2O3可能通过增加TRAIL R1/DR4和TRAIL R2/DR5基因表达、上调细胞表面TRAIL死亡受体从而增加胃癌细胞SGC7901对rhTRAIL的敏感性,两药可能联合用于治疗胃癌. AIM: To investigate the effects of subcytotoxic concentration of arsenic trioxide (As203) on the rhTRAIL-induced apoptosis in SGC7901 cells and its related mechanism. METHODS: The human gastric cancer cell line SGC7901 was treated with AS203 (1 μmol/L), rhTRAIL (500 μg/L), respectively, or in combination. The cell apoptosis was detected by flow cytometry (AnnexinV-FITC-PI assay); the expression of TRAIL R1/DR4 and TRAIL R2/DR5 on the cell surface were determined by indirect fluorescence staining and flow cytornetry; the expression of TRAIL R1/DR4 and TRAIL R2/DR5 mRNA was determined by reverse transcriptionpolymerase chain reaction (RT-PCR). RESULTS: Used along or in combination with As2O3, rhTRAIL induced apoptosis of SGC7901 cells in a time-dependent manner (12-72 h). After being exposed to rhTRAIL in combination with As203 for 24, 48 and 72 h, the apoptosis rates of SGC7901 cells were significantly higher than those of cells treated with the same concentration of rhTRAIL alone (36.49% ± 7.12%, 47.13% ± 3.44%, 55.63% ± 7.16% vs 29.78% ± 3.18%, 38.56%± 1.89%, 43.12% ± 6.23%, respectively, P〈 0.05). AS2O3, used along or in combination with rhTRAIL (500μg/L) for 24 h, increased the expression of TRAIL R1/DR4 and TRAIL R2/DR5 on the cell surface significantly (R1/DR4:29.44 ± 4.29, 26.14 ± 3.40 vs 13.45 ± 3.81, P 〈 0.05) R2/ DR5: 28.04 ± 0.79, 31.47 ± 4.56 vs 16.45 ± 5.07, P 〈 0.05), and at the same time, increased the mRNA levels of the two receptors. CONCLUSION: Subcytotoxic concentration of AS2O3 can sensitize SGC7901 cells to rhTRAIL through up-regulation of TRAIL R1/DR4 and TRAIL R2/DR5 on cell surface and their mRNA levels. Combination of rhTRAIL and AS203 can be used in the therapy of gastric cancer.
出处 《世界华人消化杂志》 CAS 北大核心 2006年第27期2679-2683,共5页 World Chinese Journal of Digestology
关键词 肿瘤坏死因子相关的凋亡诱导配体 三氧化二砷 胃癌 凋亡 Tumor necrosis factor-related apoptosisinducing ligand Arsenic trioxide Gastric carcinoma Apoptosis
  • 相关文献

参考文献9

  • 1Bouralexis S,Findlay DM,Evdokiou A.Death to the bad guys:targeting cancer via Apo2L/TRAIL.Apoptosis 2005; 10:35-51
  • 2Hopkins-Donaldson S,Ziegler A,Kurtz S,Bigosch C,Kandioler D,Ludwig C,Zangemeister-Wittke U,Stahel R.Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation.Cell Death Differ 2003; 10:356-364
  • 3Nitsch R,Bechmann I,Deisz RA,Haas D,Lehmann TN,Wendling U,Zipp F.Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL).Lancet 2000;356:827-828
  • 4Shankar S,Srivastava RK.Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation:mechanisms and clinical implications.Drug Resist Updat 2004; 7:139-156
  • 5Zhang TC,Cao EH,Qin JF.Opposite biological effects of arsenic trioxide and arsacetin involve a different regulation of signaling in human gastric cancer MGC-803 cells.Pharmacology 2002; 64:160-168
  • 6Douer D,Tallman MS.Arsenic trioxide:new clinical experience with an old medication in hematologic malignancies.J Clin Oncol 2005; 23:2396-2410
  • 7邢茂,张恩娟.三氧化二砷诱导人胃腺癌细胞SGC7901凋亡机制的研究[J].中国药房,2001,12(6):333-334. 被引量:10
  • 8Drosopoulos KG,Roberts ML,Cermak L,Sasazuki T,Shirasawa S,Andera L,Pintzas A.Transformation by oncogenic RAS sensitizes human colon cells to TRAIL-induced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway.J Biol Chem 2005; 280:22856-22867
  • 9Jin Z,McDonald ER 3rd,Dicker DT,E1-Deiry WS.Deficient tumor necrosis factor-related apoptosisinducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis.J Biol Chem 2004; 279:35829-35839

二级参考文献5

  • 1[1]Shen ZX,Cheng GQ,Ni JH,et al.Use of arsenic trioxde(As2O3)in the treatment of acute promyelocytic leukemia(APL),Ⅱ: clinical efficacy and pharmacokinetics in relapsed patients[J].Blood,1997,89: 3 354.
  • 2[2]Akao Y,Yamada H,Nakagawa Y.Arsenic-induced apoptosis in malignant cells in vitro[J].Leuk Lymphoma, 2000,37: 53.
  • 3[3]Geen DR,Reed JC.Mitochondria and apoptosis[J].Science,1998, 281: 1 309.
  • 4[4]Zamzami N,Marchetti P,Castedo CZ,et al.Reduction in mitochondrial potential constitution an early irreversible step of programmed lymphocyte death in vivo.[J].J.Exp.Med,1995,181: 1 661.
  • 5[5]Kroemer G,Zamzami N,Susis SA.Mitochondrial control of apoptosis[J].Immumo Today,1997, 18: 44.

共引文献9

同被引文献27

  • 1杨柳芹,房殿春.α-生育酚对TRAIL诱导胃癌细胞凋亡的影响及机制[J].解放军医学杂志,2005,30(9):779-781. 被引量:4
  • 2杨柳芹,房殿春.硝普钠对TRAIL诱导的胃癌细胞凋亡的影响[J].中华微生物学和免疫学杂志,2006,26(3):246-247. 被引量:3
  • 3公伟,刘军,梁飞,许世峰,杨凤辉,周旭,徐延田,于光圣,李光兵.TRAIL受体在胰腺癌中的表达[J].中国普外基础与临床杂志,2006,13(5):521-523. 被引量:8
  • 4仲飞,张世能,傅玉如,朱兆华.三氧化二砷协同肿瘤坏死因子相关细胞凋亡诱导配体抗胃癌细胞的作用及其机制[J].中华消化内镜杂志,2007,24(2):118-122. 被引量:2
  • 5Pitti RM, Marsters SA, Ruppert S, et al. Induction of apoptosis by Apo -2 ligand ,a new member of the tumor necrosis factor cytokine family [ J ]. J Biol Chem, 1996,271 (22) : 12687.
  • 6Ashkenazi A,Pai RC,Fong S,et al. Safety and antitumor- activity of recombinant soluble Apo2 ligand [ J ]. J Clin Invest, 1999,104 : 155.
  • 7Almasan A,Ashkenazi A. Apo2L/TRAIL:apoptosis signaling,biology,and potential for cancer therapy[ J]. Cytokin Growth Factor,2003,14(3 -4) :337.
  • 8Bodmer JL, Meier P, Tschopp J, et al. Cystelne 230 is essential for the structure and activity of the cytotoxic ligand TRAIL [ J ]. J Biol Chem,2000,275 ( 27 ) :20632.
  • 9Lawrence D,Shahrokh Z,Marsters S,et al. Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions [ J ]. Nat Med ,2001,7(4) :383.
  • 10Traneh A, Sharma S, Silveman C, et al. Temperature - sensifive differential affinity of TRAIL for its receptors DR5 is the highest affinity receptor[ J]. J Biol Chem,2000,275 (30) :23319.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部